HOW I TREAT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS?

QR Code

HOW I TREAT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS?

Saved in:

Bibliographic Details
Main Author:	María-Victoria Mateos
Format:	article
Language:	EN
Published:	Elsevier 2021
Subjects:	Diseases of the blood and blood-forming organs RC633-647.5
Online Access:	https://doaj.org/article/12ff639881dc4c38a8675d1d6521e3df
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Daratumumab improves the anti-myeloma effect of newly emerging multidrug therapies
by: Gopalakrishnan S, et al.
Published: (2013)

Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis
by: Foteini Theodorakakou, et al.
Published: (2021)

INSIGHTS INTO DIAGNOSIS AND MANAGEMENT OF ADVANCED MULTIPLE MYELOMA
by: Vasile Musteata, et al.
Published: (2021)

Leptomeningeal myelomatosis in previously treated high-risk kappa light chain multiple myeloma: case report and literature review
by: Ohanian M, et al.
Published: (2011)

THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
by: Ayşe Uysal, et al.
Published: (2021)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
by: Meletios A. Dimopoulos, et al.
Published: (2021)

Profile of elotuzumab and its potential in the treatment of multiple myeloma
by: Liu YC, et al.
Published: (2014)

CASE REPORT: COEXISTENCE OF CELIAC DISEASE AND MULTIPLE MYELOMA
by: Filiz YAVASOGLU, et al.
Published: (2021)

INVESTIGATION OF THE QUALIFICATION OF RADIOLOGICAL TECHNIQUES TO DETECT OSTEOLYTIC LESIONS, FRACTURES, AND OSTEOPOROSIS IN MULTIPLE MYELOMA PATIENTS
by: Atakan Turgutkaya, et al.
Published: (2021)

Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
by: Gupta VA, et al.
Published: (2013)

Multiple myeloma: optimal management and long-term disease control
by: Sriskandarajah P, et al.
Published: (2014)

CLINICAL PARAMETERS OF MULTIPLE MYELOMA PROGRESSION IN RESIDENTS OF THE GOMEL REGION OF BELARUS
by: Zhanna KOZICH, et al.
Published: (2021)

ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS
by: Mehmut TURGUT, et al.
Published: (2021)

IMPACT OF BONE MARROW FIBROSIS IN MYELOMA PATIENTS UNDERGONE AUTOLOGOUS STEM CELL TRANSPLANTATION
by: Senem Maral, et al.
Published: (2021)

A CASE DIAGNOSED WITH FOUR DIFFERENT TUMORS
by: Fatma Tuba YILDIRIM, et al.
Published: (2021)

A CASE OF POLYCYTHEMIA DIAGNOSED AS HEMOGLOBIN ANDREW-MINNEAPOLIS
by: Mustafa Bilici, et al.
Published: (2021)

Treating the elderly patient with chronic lymphocytic leukemia: current and emerging options
by: Mozaheb Z
Published: (2014)

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
by: Hans C. Hasselbalch, et al.
Published: (2021)

ACQUIRED FACTOR XIII DEFICIENCY WITH RUNX1 MUTATION, A REPORT OF TWO CASES TREATED WITH FACTOR XIII CONCENTRATE
by: Alfadil Haroon, et al.
Published: (2021)

MYSTERY OF iAMP
by: Fatma Burçin KURTİPEK, et al.
Published: (2021)

SECONDARY CHRONIC MYELOID LEUKEMIA FOLLOWING RADIOACTIVE IODINE (I131)
by: Yousef Hailan, et al.
Published: (2021)

T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT
by: Merih Reis Aras, et al.
Published: (2021)

THE EVALUATION OF CONGENITAL NEUTROPENIA PATIENTS
by: Nihal Karadaş, et al.
Published: (2021)

Preserving fertility in young patients with lymphoma: an overview
by: Patel B, et al.
Published: (2014)

Prospective identification of potential factors influencing stem cell mobilization and the necessity for plerixafor use in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation
by: Gopal Krushna Ray, et al.
Published: (2021)

CLINICAL AND LABORATORY EVALUATION OF OUR PATIENTS WITH HEREDITARY SPHEROCYTOSIS
by: Senanur Şanlı Çelik, et al.
Published: (2021)

THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19
by: Fatma YILMAZ, et al.
Published: (2021)

EXPERIENCE OF GLASDEGIB IN PATIENTS WITH ELDERLY ACUTE MYELOID LEUKEMIA
by: Nanişe Gizem FENER, et al.
Published: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
by: Monarch Shah, et al.
Published: (2021)

COMPARISON OF INDIVIDUAL PHARMACOKINETIC DOSING TOOLS IN PATIENTS WITH HEMOPHILIA A
by: Can Alp GENÇ, et al.
Published: (2021)

PONATINIB EXPERIENCE IN A PEDIATRIC CHRONIC MYELOID LEUKEMIA PATIENT
by: Serap Karaman, et al.
Published: (2021)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
by: Bodiford A, et al.
Published: (2015)

Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients
by: Rytting ME
Published: (2012)

WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?
by: Simge ERDEM, et al.
Published: (2021)

RETROSPECTIVE EVALUATION OF PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS FOLLOWED IN OUR CLINIC
by: Mehmet Can Ugur, et al.
Published: (2021)

PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
by: Seda Şahin, et al.
Published: (2021)

ASPARAGINASE INDUCED SINUS VEIN THROMBOSIS IN AN ADULT YOUNG ALL PATIENT
by: Beyza OLUK, et al.
Published: (2021)

Reticulocyte Hemoglobin Equivalent: Diagnostic Performance in Assessment of Iron Deficiency in Patients with Hypothyroidism
by: Wardah Aslam, et al.
Published: (2021)

THE EFFECT OF COMORBIDITY AND BODY MASS INDEX ON SURVIVAL IN PATIENTS WITH MARGINAL ZONE LYMPHOMA
by: Esra TURAN ERKEK, et al.
Published: (2021)

EVALUATION OF THE FREQUENCY OF ARTERIAL AND VENOUS THROMBOSIS AND PREDISPOSING FACTORS IN PATIENTS USING ELTROMBOPAG
by: Derya Deniz Kurekci, et al.
Published: (2021)